Frequent brain metastases during treatment with BRAF/MEK inhibitors: A retrospective single institutional study
Abstract
Recent clinical trials revealed that both immune checkpoint inhibitors (ICI) and BRAF/MEK inhibitors significantly prolonged survival in melanoma patients when used for both advanced stage disease and postoperative adjuvant therapy. Although BRAF/MEK inhibitors are associated with a higher objective response rate than ICI, most patients relapse during treatment. However, progression patterns during treatment with BRAF/MEK inhibitors have not...
Paper Details
Title
Frequent brain metastases during treatment with BRAF/MEK inhibitors: A retrospective single institutional study
Published Date
Jun 29, 2020
Journal
Volume
47
Issue
10
Pages
1191 - 1194
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History